Published preclinical data demonstrate unprecedented Ago2 loading following administration of single subcutaneous siRNA dose, leading…
CORAL GABLES, Fla., April 20, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
CORAL GABLES, Fla., April 20, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
MALVERN, Pa., April 20, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
MALVERN, Pa., April 20, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 20, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics NV. (Nasdaq:…
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 20, 2023 (GLOBE NEWSWIRE) — ProQR Therapeutics NV. (Nasdaq:…
VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
STOUGHTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified…
STOUGHTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified…
BOSTON, April 20, 2023 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted…
BOSTON, April 20, 2023 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted…
Fourth major clinical trial to select PharmAla Biotech as supplier in Australia VANCOUVER, British Columbia,…
Fourth major clinical trial to select PharmAla Biotech as supplier in Australia VANCOUVER, British Columbia,…
– Presentations to cover updated clinical and preclinical data on pipeline candidates in Company’s thyroid…
– Presentations to cover updated clinical and preclinical data on pipeline candidates in Company’s thyroid…
Preclinical data from LBIO-115 exon 51 program demonstrate superior levels of exon-skipping that result in…
Preclinical data from LBIO-115 exon 51 program demonstrate superior levels of exon-skipping that result in…
WARREN, N.J., April 20, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company”…